ClinicalTrials.gg
TerminatedNCT01883947MESTUpdated Jun 18, 2019

Effects of Touch Massage in the Sub-acute Phase After Stroke

An interventional study of Touch massage and non-TENS in Stroke, sponsored by Umeå University. Terminated at 1 site in Sweden. Per ClinicalTrials.gov, last updated 2019-06-18.

Sponsored by Umeå University · Not applicable, Interventional, and Supportive care

Why this study was terminated
too long inclusion phase due to difficulties to find eligible participants.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Sex
All
01

Study summary

The aim is to study effects of touch massage in the sub-acute phase after stroke in two main areas; general health and independence.The hypothesis are that; touch massage in the sub-acute phase after stroke decreases anxiety and pain, increases health related-quality of life, decrease physiological stress responses, increase sensorimotor function, decrease disability, and increase activity in sensorimotor areas and decrease redundant brain activity in motor-related areas.

Read the detailed description

Despite high quality stroke care in Sweden, decreased sensorimotor function, anxiety and pain remains one year after stroke and lead to impaired health and dependence as well as high health care costs. It is therefore urgent to find new rehabilitation strategies. There is some knowledge about effects of touch massage among healthy and patients with ill-health conditions but no study have evaluated touch massage in the sub-acute phase of stroke. Therefore the aim in this project is to study effects of t touch massage in the sub-acute phase after stroke in two main areas; general health and independence.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Stroke
  • Massage
  • General Health
  • Independence
03

In context

Stroke

7,441 studies on the registry are indexed under Stroke; 2,012 are open to participants now.

This study's enrollment of 50 is close to the median of 50 across 5,482 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Umeå University is the lead sponsor of 271 studies on the registry; 60 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • stroke defined according to Trial of ORG 10172 in Acute Stroke Treatment (TOAST) and The Oxford Community Stroke Project Classification (OSPC),
  • impaired finger tapping on the affected side of the body,
  • the ability to flex the wrist 20° from substrate on affected side of the body

Exclusion Criteria:individuals with

  • cancerous tumors,
  • infections with fever,
  • neurologic or psychiatric disease,
  • alcohol or drug addiction,
  • conditions that impede communication.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Touch massage

    Intervention group will receive touch massage on hands and feet and the intervention will start one week after the onset of stroke and last for 30 minutes each time, five days a week for two weeks

    Procedure: Touch massage

  • Sham comparator
    non-TENS

    The sham treatment will start one week after the onset of stroke and last for 30 minutes each time, five days a week for two weeks

    Other: non-TENS

Interventions

  • ProcedureTouch massage

    Touch massage is a gentle massage with strokes on hands, arms, feet and legs with at pressure of 2.5 N which is more gentle than Swedish massage but harder than strokes performed with a brush. The speed of the strokes is about 1-5 cm/sec. During the massage, the subjects will lie on a bed. Intervention group will receive touch massage on hands and feet and the intervention will start one week after the onset of stroke and last for 30 minutes each time, five days a week for two weeks

  • Othernon-TENS

    Subjects in the control group will have sham treatment which is a non-active transcutaneous electrical nerve stimulation (non-TENS), while they lie in bed with electrodes attached to the skin of the affected arm. The device will be manipulated in a way so that no electrical impulses will reach the electrodes. During treatment, the masseur will remain in the room without initiating any conversation.

06

What researchers measure

Primary outcomes

  1. State-Trait Anxiety Scale

    Assessment of self-rated anxiety on two subscales. Traits are stable over time and not sensitive to occasional stressors. States are sensitive for occasional stressors assessing current emotional state

    Time frame: 2 month

Secondary outcomes

  1. VAS

    To assess self-rated pain

    Time frame: 2 weeks

  2. Nottingham Health Profile

    This is a self-rating scale which assess Health related quality of life

    Time frame: 2 weeks

  3. ECG

    evaluate heart rate variability which reflects activity in the autonomic nervous system

    Time frame: 2 weeks

  4. Salivary cortisol

    To assess effects on stress responses

    Time frame: 2 weeks

  5. Blood pressure

    to assess effects on stress responses

    Time frame: 2 weeks

  6. Shape Texture Identification Test

    will be used to assess touch discrimination

    Time frame: 2 month

  7. Box and Blocks

    will be used to test gross dexterity

    Time frame: 2 month

  8. Nine Hole Peg

    will be used to test fine motor dexterity,

    Time frame: 2 month

  9. Jamar® Hydraulic Hand Dynamometer

    will be used to assess grip strength

    Time frame: 2 month

  10. movement laboratory with high-speed cameras

    Temporal and spatial kinematic variables will be evaluated

    Time frame: 2 month

  11. Functional magnetic resonance imaging

    Evaluation of brain activity while patient perform finger-tapping/movement with the paretic hand

    Time frame: 2 weeks

  12. Barthel index and Modified Ranking scale

    will be used to assess disability after stroke

    Time frame: 2 month

07

Study locations

1 site
  • Norrlands university hospital
    Umeå, 90187, Sweden
08

References and documents

Publications

  • Lamas K, Hager C, Lindgren L, Wester P, Brulin C. Does touch massage facilitate recovery after stroke? A study protocol of a randomized controlled trial. BMC Complement Altern Med. 2016 Feb 4;16:50. doi: 10.1186/s12906-016-1029-9. PubMed 26846253 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2013, a primary completion of Jun 2017 and a completion of Jun 2018. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
May 27, 2013
First posted
Jun 21, 2013
Start
Jan 2013
Primary completionActual
Jun 2017
CompletionActual
Jun 2018
Last update
Jun 18, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01883947
Lead sponsor
Umeå University
Responsible party
Kristina Lämås (PhD, Umeå University) — Principal investigator
First posted
Jun 21, 2013
Start date
Jan 2013
Primary completion
Jun 2017
Completion
Jun 2018
Last update
Jun 18, 2019

Study contacts

Kristina Lämås, PhD
principal investigator · Umea University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion